Oritavancin is a lipoglycopeptide with broad-spectrum activity against Gram-positive pathogens, such as staphylococci, including methicillin resistant Staphylococcus aureus (MRSA), streptococci and enterococci.

ComASP庐 (Compact Antimicrobial Susceptibility Panel) Oritavancin is a 2-test panel containing the dried up antibiotic in 15 two-fold dilutions (0.001-16 ?g/ml).

ComASP庐 Oritavancin is used to perform the broth microdilution (BMD) method for the antimicrobial susceptibility testing of Oritavancin as recommended by international standards (i.e. CLSI, EUCAST, ISO 20776-1:2006).

Choose among one of the following nine preset panels or request customized 32-well panel formats with over 100 antibiotics available:

路 Oritavancin
路 Colistin
路 Piperacillin-tazobactam
路 Colistin / Piperacillin-tazobactam
路 Ceftolozane-tazobactam / Ceftazidime-avibactam
路 Vancomycin / Teicoplanin
路 Ceftolozane-tazobactam
路 Vancomycin
路 Antifungal

Learn more about ComASP庐